Recognizing the extensive medical applications of STAMPs, C3J is developing the potential of STAMP technology to modulate the microbiome both within the oral cavity and for broader medical applications. Our acquisition in 2018 of an engineered phage platform from Synthetic Genomics, Inc. helps us develop targeted antimicrobials across multiple indications to combat emerging multidrug-resistant infections (Read the Press Release).

Medical Pipeline | Dental Pipeline